Therefore, we propose that the impact of cAMP/PKA signaling on ERα activity explains how PAICS levels can be linked to estrogen-independent and 4-OHT–resistant proliferation of ERα+ breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.